Recovery from the Jab
By Craig Paardekooper

Background
Different age groups received different dosages of the COVID 19 vaccine, and only some age groups received
the booster in 2021 and 2022. The aim of this study was to see if these different dosages effected recovery fromadverse reactions.

Data Sources
All data is publicly available as downloadable files - https://www.vaersaware.com/post/vaers-nov-11thdownloadable-files.

Dosages
Reference :https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://stacks.cdc.gov/view/cdc/11
8388/cdc_118388_DS1.pdf&ved=2ahUKEwiu6Ja4zpGGAxX7_rsIHXmHD3AQFnoECA8QAQ&usg=AOvVaw2NUG
DJ9duX5m81cebwY4GE
MONOVALENT - MODERNACAPLABEL BORDERAMOUNT

AGE

Blue Cap

Magenta

25mcg

under 6Red Cap

Light-Blue

100mcg

12 and older

AMOUNT

AGE

Maroon3mcg

under 5

Orange10mcg

5-11 years

Grey

30mcg

12 and over

MONOVALENT - PFIZERCAPLABEL BORDERBOOSTERS
In 2021 Booster doses were only authorised for over 18s
See Moderna COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers 08312022 (fda.gov)
Age 12 to 17

No booster

Age 18 +Booster

Method
Every record submitted to VAERS allows the inputter to record their “Recovery” status in a column called“RECOVD”. They can enter ••••“Y” = Recovered“N” = not recovered“U” = Unknown
Blank

So here are the steps I followed 1. I used excel to select the age column for all records for 2021
2. I created a pivot table to count the total number of records for each age
3. Then I filtered the records for “RECOVD” = “Y”, Then I recounted the number of records for each age
where “RECOVD” = “Y”
4. This gave me the % of reports for each age where a recovery was reported.
This procedure was repeated for all records for 2022. The graphs were plotted as scattergrams using excel.
5. Then I filtered the records for “RECOVD” = “N”, Then I recounted the number of records for each age
where “RECOVD” = “N”
6. This gave me the % of reports for each age where a “not recovered” was reported.
I compared the 2021 graph for “recovered” with the 2022 graph for “recovered”
I compared the 2021 graph for “not recovered” with the 2022 graph for “not recovered”

Results : Status = Recovered
Based on 2021 VAERS USA data only

The graph seems to show a partitioning of recovery into 3 clusters –•••under 12s
12-17
18 and over

These 3 clusters correspond to the 3 different dosage schedules.
There appears to be a progressive decline in recovery for over 18s.
It is possible that differences in dosage might explain this pattern.
Over18s qualified for boosters.

Further Investigation
If “recovered” status varies with dose, then the same patterns should persist for 2022 and 2023 data.
If “recovered” status follows this pattern, then “not recovered” status should follow this pattern.
Reports with booster status should show a higher % of ADRs than reports with monovalent status.

Here is the 2022 data. It shows the same sudden drop after the age of 17, but this time down to a more or lessconstant plateau until the age of 70. Boosters were only authorised for 18 and over.
In 2021 boosters were being adopted for over 18s but the uptake was age dependent with earliest adopters
being the older recipients. By 2022 adoption was more uniform for all 18 and over.

Comparison between 2021 and 2022 VAERS USA : % of reports with status = “recovered” vs Age
There is a similarity of shape for both plots – showing –••••a sharp decline after 18
a lower rate of recovery in 2022 compared to 2021 for all ages
a steeper decline of recovery for young adults
a decline of recovery for middle ages even below that of over 60s

Results : Status = Not Recovered

Here, with 2021 data, you can see a large increase after the age of 18 in the % of reports with a status of “notrecovered”. This increase peaks for the middle-aged to such an extent that it eclipses the incidence of nonrecovery for the elderly.
In the graph below I have plotted the same percentages subtracted from 100, so you can see how they comparewith the graph for % recovered.

So the records with the status of “not recovered” confirm the same pattern as the records with status“recovered”, namely that there is a massive drop in recovery from age 18 onwards.

Here, with 2022 data, you can see the same large increase after the age of 18 in the % of reports with a statusof “not recovered”. This increase peaks for the middle-aged to such an extent that it eclipses the incidence of
non-recovery for the elderly.
In the graph below I have plotted the same percentages subtracted from 100, so you can see how they comparewith the graph for % recovered.

Now to compare “not recovered” in 2021 with “not recovered” in 2022

In both years the data follows a very similar pattern. When we subtract the % of not recovered from 100 we
obtain a strong confirmation of the sharp reduction in recovery after the age of 18.

Summary
We have found the same patterns of recovery persist for 2021 and 2022 data.
We have found the same patterns of non-recovery persist for 2021 and 2022 data.
These patterns show a significant drop in recovery after the age of 18, and a significant drop in recovery for
middle-aged below that of even the elderly
The recovery rate for people aged 25-55 is pushed far lower than the over 60s ! If these effects are due to the“booster”, then people are literally being boosted to death.
If the booster is responsible for this pattern then reports with booster status should show a higher % of ADRs
for each age compared to reports with monovalent status.

Recovery from 1991 to 2023
The following graphs show the percentage of reports where status = “recovered” for each age group following
all reported vaccination adverse reactions for that year. This includes all vaccines not just Covid 19 jabs.
Over this period there is a significant decline in the % of reports where status = “recovered”

Lower Limit
From 1994 to 2004 : min 50% recovery
From 2010 to 2013 : min 40% recovery
From 2014 to 2016 : min 30% recovery
From 2022 : min 20% recovery

Upper Limits
These also drop over this period
Statistics will be published in the next update.

Why are fewer and fewer people recovering from the jabs. From 2003 onwards, there is a steady decline (seemean values). Over the period 1991 to 2023, the percentage of reports with recovery is reduced from about
60% to 30%. The change is incremental. If intentional, this might be a long term depopulation strategy.

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available, for example for age 2.58
years. Exclusion of these outliers will result in a lower mean.

You may prefer a line plotof the data which isshown to the left.
Notice the catastrophic
drop in recovery foryoung adults. Something
is being given to young
adults and middle-aged
recipients in 1991-3 but
not given to people under
20 or over 60. It is likely
to be a new vaccine
introduced at this time.

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers will
result in a lower mean.

You may prefer a line plotof the data which is shown
to the left.
1992 shows a lessening of
the effect of whatever was
introduced in 1991. But it
also shows a rollout of it tothe over 60s producing a
10% drop in their recovery
rates.

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers will
result in a lower mean.

1993 shows a significant
bounce back of young
adults and middle aged
from what ever was
introduced in 1991.
Perhaps the drug was
nolonger being deployed tothose age groups. Their
recovery rate bounces backfrom 30% to 60%.
However elderly groups stillseem to be adversely
effected.

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers will
result in a lower mean.

By 1994, the elderly havebounced back too, though
they still have a lingering
effect.
The plot now looks more
like a horizontal line.
As you will see, from 1994
to 1999 this horizontal line
more or less persists,though it declines between
1994 and 1997 for adult
populations only,
suggesting that vaccines ofincreased toxicity werebeing deployed to adult
populations.

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers
will result in a lower mean.

In 1995 you can see that
there has been asignificant drop in
recovery for adult (over 20
years) compared to under
20. The drop in recovery is
about 10%.

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers
will result in a lower mean.

The drop noticed in
1995, now persists. It
is now worse foryoung adults – about a
20% drop in recovery
relative to 1994.
This drop also effects
middle-aged and over60s.

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers will
result in a lower mean.

1997 shows apersistence of the drop
observed in 1996.

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers
will result in a lower mean.

1998 shows a bounceback of 10% for young
adults and middle aged.
However, it looks as if it
has now been deployed
to 12 + year olds since
they are showing a 10%
reduction.

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers
will result in a lower mean.

1999 is more like a flat line
again.
A “new normal” seems tohave been established in
the 50-60 band, rather thanthe earlier 60-70 band.

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers
will result in a lower mean.

In 2000 somethingcatastrophic
happened.
As in 1991 there is asignificant depressionof recovery for young
adults and middleaged.

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers
will result in a lower mean.

In 2001, there is a bounceback from what ever was
introduced in 2000 for
young adults and middleaged, though it is notcomplete recovery.

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers
will result in a lower mean.

In 2002 the bounce backcontinues.

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers
will result in a lower mean.

2003 further bounceback.
The plot looks like ahorizontal line,
establishing a clear
baseline at about 50%
recovery.

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers will
result in a lower mean.

2004 : Massive global
drop in vaccine
recovery. Baseline
now at 40%.
Possibly due tointroduction of thefirst SARS vaccine.
Adult recovery clearly
below that of teens.

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers will
result in a lower mean.

2005 : Significant bounceback from 2004
intervention.
Young adult recovery still
below that of teensPlease note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers
will result in a lower mean.

2006 : This year is thestart of a persistentdecline.
30+ recovery below thatof younger ages.

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers
will result in a lower mean.

2007 : Drop in recovery
for the over 70s.
Perhaps they were being
medicated in care-homes
and hospitals.
Baseline for young adults
and middle-aged looks to
be 50%

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers
will result in a lower mean.

2008 : Decline spreading
to the over 60s.
Were they starting withthe elderly this time?

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers
will result in a lower mean.

2009 : Decline persists
and begins to effect theover 50s.

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers
will result in a lower mean.

2010 : Decline spreads
to the over 30s.

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers
will result in a lower mean.

2011 : A “new normal”
established for adults –at a base line of 40%
recovery.
Teens seem unaffected.

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers will
result in a lower mean.

2012 : The decline
receives a new impetus.
A further decline isobserved in the over 60s.
Once again, they arestarting with the elderly.

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers will
result in a lower mean.

2013 : The decline
spreads to the over 50s

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers
will result in a lower mean.

2014 : Decline becomes global
for all age groups.
“New normal” established witha baseline of 35%.

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers will
result in a lower mean.

2015 : Further global
reduction of recovery
for all age groups.
“New normal”
established with abaseline of 30%.

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers
will result in a lower mean.

2016 : Partial bounceback of teens.
But adult recipients begin
to drop below 30%
recovery.

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers will
result in a lower mean.

2017 : Recovery rate for theover 80s shows a drop to
20% baseline.
There is also a noticeable
decline in recovery for theover 40s to a 25% baseline.
It looks as if they started witholder age groups again.

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers
will result in a lower mean.

2018 : The decline has
spread to the over 30s.
It seems to be focused on
the 30-50 age range.

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers
will result in a lower mean.

2019 : Decline spreads tothe over 20s.
It seems to be focusedon the 20-30 age range.

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers
will result in a lower mean.

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers will
result in a lower mean.

2021 : Significant reduction
in recovery rates. Now atabout 32 % for everyone
over 40 years old.

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers
will result in a lower mean.

2022 : “New normal”
established at 22%
baseline for all adults.
Teen recovery declines
to 35%.

Please note, these stats include all data including outliers. Outliers arise fromage groups where only 1 or 2 reports are available. Exclusion of these outliers
will result in a lower mean.

2023 : Teen and childrecovery now pulled
down below adults –reaching as low as 18%
recovery.
Young adults bounceback to 32%.
Bounce back of middleaged to 27% and over
60s to 35%

A Significant Lowering of Recovery
At the very least the charts shown in this study should alert us that the jabs taken in 2022 had a significantly
lower recovery compared to jabs taken in 2021.
This reduction was across 100 independent samples (each age group is a sample), and this reduced recovery
rate followed their age so that adjacent ages had similar reductions.
So the effect is very strong.

Here is a boxplot showing the spread of recovery for ALL AGES , each year from 1991 to 2023 for all vaccines in
VAERS (there are 100 different vaccines)
Each bar represents the spread for all age groups for that year (from age 0.08 to age 85 years)

A continuous decline in % recovery is observed. Large drops in recovery are observed for the years –1991, 1992, 1996, 2000, 2004, 2012, 2022

Here is a boxplot showing the spread of recovery for 20 YEARS AND UNDER , for each year from 1991 to 2023
for all vaccines in VAERS (there are 100 different vaccines)
Each bar represents the spread for age groups for that year (from age 0.08 to age 20 years)

A continuous decline in % recovery is observed. The graph for 20s and under shows some distinct declines inthe years 1991, 1998, 1999, 2004-2006, 2013-2015, 2022

Here is a boxplot showing the spread of recovery for 12 YEARS AND UNDER , for each year from 1991 to 2023
for all vaccines in VAERS (there are 100 different vaccines)
Each bar represents the spread for age groups for that year (from age 0.08 to age 12 years)

A continuous decline in % recovery is observed. The graph for 12 yrs and under shows distinct declines in theyears 1991, 1994, 1999, 2004, 2013-15, but there is a constant decline in recovery across the whole period.

These findings suggest that the vaccines, alone or in combination, are having an increasingly harmful effect.
Perhaps this harm is cumulative with prior vaccines received by an individual or with the large number ofconcurrent vaccines, or it may be due to the progressively higher toxicity of individual vaccines.
It could be all of these
The next mandated vaccine may reduce our recovery rates further. Extreme caution is advised.

We have observed a progressive decline in the “new normal” for recovery rates. The decline is incremental
though there are also rapid “catastrophic” declines in some years that require investigation as to what vaccines
may have caused these declines.
The incremental approach to inducing decline may serve the purpose of allaying public resistance andobtaining their willing compliance. Without general compliance a further decline is not achievable.